Skip to content
Assyro AI
FDA Orange Book · active-ingredient family

Diazoxide

Diazoxide: 3 brands, 3 generics; first approved Aug 26, 1987; generic available.

Generic availableHas discontinued products
Generic status & protection

Generic available: 3 ANDA applications approved.

Brands (NDA)
3
Generics (ANDA)
3
Listed patents
0
Presentations
7

Brand (NDA) products

Originator applications
Ask AI
  • NDA 017453-
    Approved strengths under this FDA application.
    StrengthDosage formRouteStatusTE
    50MG/MLSUSPENSIONORALRxAB
  • NDA 017425-2 strengths
    Approved strengths under this FDA application.
    StrengthDosage formRouteStatusTE
    50MGCAPSULEORALDiscontinued-
    100MGCAPSULEORALDiscontinued-
  • NDA 016996-
    Approved strengths under this FDA application.
    StrengthDosage formRouteStatusTE
    15MG/MLINJECTABLEINJECTIONDiscontinued-

Generic (ANDA) products (3)

Abbreviated applications
Ask AI
  • DIAZOXIDE
    ANDA 2107992020
    Approved strengths under this FDA application.
    StrengthDosage formRouteStatusTE
    50MG/MLSUSPENSIONORALRxAB
  • DIAZOXIDE
    ANDA 2110502019
    Approved strengths under this FDA application.
    StrengthDosage formRouteStatusTE
    50MG/MLSUSPENSIONORALRxAB
  • DIAZOXIDE
    ANDA 0715191987
    Approved strengths under this FDA application.
    StrengthDosage formRouteStatusTE
    15MG/MLINJECTABLEINJECTIONDiscontinued-

Listed patents

Orange Book patent file

No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.

Approval history

FDA approval span
Ask AI
First approval
39 yr 10 mo ago
Most recent approval
6 yr 5 mo ago

Approvals span 1987–2020 across 6 FDA applications.

Brand (NDA) 350%
Generic (ANDA) 350%

Diazoxide: frequently asked questions

Generics, reference-listed drug, patents, and exclusivity for this active ingredient, from the FDA Orange Book.

Built directly from the FDA Orange Book data file (products, patents, and exclusivity). TE codes, RLD/RS flags, patent expirations, and exclusivity dates match the official FDA record. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.

Related FDA reference tools

Assyro Intelligence

Ask anything about Diazoxide

Cited answers from FDA, EMA, Health Canada, PubMed and ClinicalTrials.gov, in seconds. Free, no sign-up.

  • PubMed
  • ClinicalTrials.gov
  • FDA
  • Health Canada
  • EMA
  • ICH

Evaluating for a team? Book a demo